Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio.
Hum Mutat. 2017 Oct;38(10):1372-1377. doi: 10.1002/humu.23288. Epub 2017 Jul 17.
Germline mutations in the tumor-suppressor gene PTEN predispose to subsets of Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome, and autism. Evidence-based classification of PTEN variants as either deleterious or benign is urgently needed for accurate molecular diagnosis and gene-informed genetic counseling. We studied 34 different germline PTEN intronic variants from 61 CS patients, characterized their PTEN mRNA processing, and analyzed PTEN expression and downstream readouts of P-AKT and P-ERK1/2. While we found that many mutations near splice junctions result in exon skipping, we also identified the presence of cryptic splicing that resulted in premature termination or a shift in isoform usage. PTEN protein expression is significantly lower in the group with splicing changes while P-AKT, but not P-ERK1/2, is significantly increased. Our observations of these PTEN intronic variants should contribute to the determination of pathogenicity of PTEN intronic variants and aid in genetic counseling.
肿瘤抑制基因 PTEN 的种系突变使 Cowden 综合征 (CS)、Bannayan-Riley-Ruvalcaba 综合征和自闭症的某些亚型具有遗传易感性。为了进行准确的分子诊断和基于基因的遗传咨询,迫切需要将 PTEN 变异体分类为有害或良性。我们研究了来自 61 例 CS 患者的 34 种不同的 PTEN 内含子种系突变,分析了它们的 PTEN mRNA 加工,并检测了 PTEN 表达及其下游 P-AKT 和 P-ERK1/2 的变化。虽然我们发现许多靠近剪接位点的突变导致外显子跳跃,但我们也发现了存在剪接的隐匿性,导致提前终止或异构体使用的转变。在发生剪接改变的组中,PTEN 蛋白表达明显降低,而 P-AKT 表达增加,P-ERK1/2 表达没有明显增加。我们对这些 PTEN 内含子变异的观察结果应有助于确定 PTEN 内含子变异的致病性,并有助于遗传咨询。